Abstract
Endo peptidyl epoxides, in which the central epoxidic moiety replaces the scissile amide bond of a P3-P3′ peptide, were designed as cysteine proteases inhibitors. The additional P′-S′ interactions, relative to those of an exo peptidyl epoxide of the same P3-P1 sequence, significantly improved affinity to the enzymes papain and cathepsin B, but also changed the mode of inhibition from active-site directed inactivation to reversible competitive inhibition. Computational models rationalize the binding affinity and the inhibition mechanism.
Original language | English |
---|---|
Pages (from-to) | 9032-9039 |
Number of pages | 8 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 16 |
Issue number | 19 |
DOIs | |
State | Published - 1 Oct 2008 |
Bibliographical note
Funding Information:This work was supported by The Israel Science Foundation (Grant No. 1115/04) and by the ‘Marcus Center for Pharmaceutical and Medicinal Chemistry’ at Bar Ilan University.
Funding
This work was supported by The Israel Science Foundation (Grant No. 1115/04) and by the ‘Marcus Center for Pharmaceutical and Medicinal Chemistry’ at Bar Ilan University.
Funders | Funder number |
---|---|
Bar-Ilan University | |
Israel Science Foundation | 1115/04 |
Keywords
- Cathepsin B
- Endo peptidyl epoxides
- Enzyme inhibitors
- Papain
- Peptidomimetics
- Structure-activity relationships